This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Novartis Ag, University of Pennsylvania. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3,978 
1 out of 2,663 
Years Active: 2023
Title: The Innovative Contributions of Pamela Shaw
Introduction
Pamela Shaw is a notable inventor based in Seattle, Washington. She has made significant contributions to the field of medical research, particularly in understanding cytokine release syndrome (CRS). Her work has implications for improving patient outcomes in various clinical settings.
Latest Patents
Pamela Shaw holds a patent for "Biomarkers predictive of cytokine release syndrome." This patent focuses on the identification and use of biomarkers, including analytes and gene expression profiles, that have clinical relevance to CRS. This innovation is crucial for advancing the understanding and treatment of this condition.
Career Highlights
Throughout her career, Pamela has worked with prominent organizations such as Novartis AG and the University of Pennsylvania. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Pamela has collaborated with notable colleagues, including Alfred Garfall and Alex Ganetsky. These partnerships have enhanced her research and expanded the impact of her work in the medical community.
Conclusion
Pamela Shaw's innovative contributions to the field of cytokine release syndrome research highlight her dedication to improving healthcare outcomes. Her patent and collaborations reflect her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile